Baxter International Inc

Baxter International Inc. is a global healthcare company that develops and supplies a broad spectrum of medical products and services through its various subsidiaries. The company's offerings encompass vital areas such as kidney care, including peritoneal and hemodialysis solutions, along with related therapies and services. It provides essential intravenous (IV) solutions, infusion pumps, administration sets, and drug reconstitution devices. Additionally, Baxter supports hospital pharmacies with premixed and oncology drug formulations, inhaled anesthetics, critical care products, and compounding services. For surgical procedures, Baxter manufactures biological products and medical devices designed to facilitate hemostasis, tissue sealing, and adhesion prevention. It also specializes in intensive care unit (ICU) treatments like continuous renal replacement and other organ support therapies. The company's portfolio extends to integrated connected care solutions, featuring advanced devices, software, communication tools, and integration technologies. Furthermore, Baxter delivers comprehensive patient monitoring and diagnostic tools for detecting, treating, and managing a wide range of illnesses, including respiratory, cardiac, vision, and physical assessment needs, as well as providing specialized surgical suite equipment like video systems, operating tables, and precision positioning devices. Beyond its own products, Baxter offers contract manufacturing and development services to pharmaceutical and biopharmaceutical partners. These diverse products and services are utilized across numerous healthcare settings, from hospitals, kidney dialysis centers, nursing homes, and rehabilitation facilities to doctors' offices and directly by patients at home under medical supervision. Baxter markets its offerings in approximately 100 countries, leveraging a direct sales force, independent distributors, drug wholesalers, and specialized pharmacy or alternative site channels. Established in 1931 and headquartered in Deerfield, Illinois, the company also has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules.